The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
7cDS5eMv2AAnjcZT
